Edge Advisors, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Edge Advisors, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2018$11,000
-42.1%
128
-51.9%
0.00%
-50.0%
Q1 2018$19,000
+26.7%
2660.0%0.00%
+100.0%
Q4 2017$15,000
+36.4%
2660.0%0.00%0.0%
Q3 2017$11,000
-35.3%
266
-40.5%
0.00%
-50.0%
Q2 2017$17,0000.0%4470.0%0.00%0.0%
Q1 2017$17,0000.0%447
+1.6%
0.00%0.0%
Q4 2016$17,0004400.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2017
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders